Articles

Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors

Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands
Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands
Rheumatology, VU University Medical Center, Amsterdam, The Netherlands
The Fred Wyszkowski Cancer Research Lab, Technion-Israel Institute of Technology, Haifa, Israel
Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands;Hematology, VU University Medical Center, Amsterdam, The Netherlands
Research Department, Onyx Pharmaceuticals, South San Francisco, CA, USA
Research Department, Onyx Pharmaceuticals, South San Francisco, CA, USA
Research Department, Onyx Pharmaceuticals, South San Francisco, CA, USA
Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Canada
Hematology, VU University Medical Center, Amsterdam, The Netherlands
Dutch Childhood Oncology Group, The Hague, The Netherlands
Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TXT, USA
Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands
Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands;Hematology, VU University Medical Center, Amsterdam, The Netherlands
Vol. 98 No. 12 (2013): December, 2013 https://doi.org/10.3324/haematol.2013.092411